Cargando…
Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials
We conducted a systematic review and meta-analysis of randomized control trials to formally assess the safety and efficacy of autologous whole cell vaccines as immunotherapies for solid tumors. Our primary safety outcome was number, and grade of adverse events. Our primary efficacy outcome was clini...
Autores principales: | Bastin, Donald J., Montroy, Joshua, Kennedy, Michael A., Martel, Andre B., Shorr, Risa, Ghiasi, Maryam, Boucher, Dominique M., Wong, Boaz, Gresham, Louise, Diallo, Jean-Simon, Fergusson, Dean A., Lalu, Manoj M., Kekre, Natasha, Auer, Rebecca C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971202/ https://www.ncbi.nlm.nih.gov/pubmed/36849805 http://dx.doi.org/10.1038/s41598-023-29630-9 |
Ejemplares similares
-
Safety and efficacy of autologous tumour cell vaccines as a cancer therapeutic to treat solid tumours and haematological malignancies: a meta-analysis protocol for two systematic reviews
por: Khan, Sarwat T, et al.
Publicado: (2020) -
Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: a preclinical systematic review protocol
por: Tieu, Alvin, et al.
Publicado: (2019) -
Identifying effect modifiers of CAR-T cell therapeutic efficacy: a systematic review and individual patient data meta-analysis protocol
por: Lalu, Manoj M., et al.
Publicado: (2023) -
Efficacy and safety of chimeric antigen receptor T-cell (CAR-T) therapy in patients with haematological and solid malignancies: protocol for a systematic review and meta-analysis
por: Grigor, Emma J M, et al.
Publicado: (2017) -
Mesenchymal Stromal Cells As a Therapeutic Intervention for COVID-19: Second Iteration of a Living Systematic Review and Meta-Analysis
por: Kirkham, Aidan, et al.
Publicado: (2022)